Representation in Clinical Research

Representation matters in clinical trials. When certain populations are underrepresented, the treatments developed may not work as effectively for everyone. Increasing the diversity of participants in clinical trials enables pharmaceutical companies not only to develop treatments that address the needs of diverse populations, but also to enable more equitable healthcare.

Our commitment goes beyond individual studies. We aim to foster trust, engagement, and inclusion across all aspects of clinical research. By working together, we can break down barriers and ensure that every voice is heard in the development of new medicines and deliver better outcomes for patients everywhere.

Our recent Education Forum - Inclusive Research Starts Here - highlighted the experiences of patients, clinicians, and advocates who remind us why representation in clinical trials is essential. Their voices bring attention to the barriers to representation, from lack of trust and awareness to practical challenges in daily life, and why we must work differently to reach and engage underrepresented communities.

We aim to build trust, strengthen partnerships, and embed inclusion across every stage of clinical research. By working together, we can break down barriers and deliver better outcomes for patients everywhere.

Representative Clinical Trials Video - YouTube

Representative Clinical Trials Video

Inclusive Clinical Trials Education Forum - YouTube

Inclusive Clinical Trials Education Forum

NP-GB-107115 March 2026

References